Jasmina M. Mallet

Creteil, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 108 publications

From non-specific biomarker to targeted action: transdiagnostic and sex-specific drivers of high-CRP status in severe mental illness across the FondaMental Advanced Centers of Expertise (FACE) cohorts.

From non-specific biomarker to targeted action: transdiagnostic and sex-specific drivers of high-CRP status in severe mental illness across the FondaMental Advanced Centers of Expertise (FACE) cohorts.

Journal: Brain, behavior, and immunity

Published: October 27, 2025

A dimensional approach to negative symptoms in psychiatric disorders

A dimensional approach to negative symptoms in psychiatric disorders

Journal: Medecine sciences : M/S

Published: May 26, 2025

Cognitive flexibility: a key cognitive dimension

Cognitive flexibility: a key cognitive dimension

Journal: Medecine sciences : M/S

Published: May 26, 2025

Sensory anomalies: an objective and quantifiable dimension in mental health

Sensory anomalies: an objective and quantifiable dimension in mental health

Journal: Medecine sciences : M/S

Published: May 26, 2025

Neurodevelopment: a transnosographic dimension

Neurodevelopment: a transnosographic dimension

Journal: Medecine sciences : M/S

Published: May 26, 2025

Tobacco craving and suicidal risk in a cohort of subjects with schizophrenia: results from the national FACE-SZ cohort.

Tobacco craving and suicidal risk in a cohort of subjects with schizophrenia: results from the national FACE-SZ cohort.

Journal: Psychiatry research

Published: May 15, 2025

Flowers for Algernon: How metacognition affects quality of life in schizophrenia. Structural equation modeling with the FACE-SZ cohort.

Flowers for Algernon: How metacognition affects quality of life in schizophrenia. Structural equation modeling with the FACE-SZ cohort.

Journal: Comprehensive psychiatry

Published: March 05, 2025

QT Interval, Antipsychotics and Correlates Among Patients with Schizophrenia: Cross-Sectional Data from the Multicentric Real-World FACE-SZ.

QT Interval, Antipsychotics and Correlates Among Patients with Schizophrenia: Cross-Sectional Data from the Multicentric Real-World FACE-SZ.

Journal: Drug safety

Published: February 09, 2025

Pro-inflammatory processes and metabolic syndrome: combined risk of resistance to treatment in patients with schizophrenia from the FACE-SZ cohort.

Pro-inflammatory processes and metabolic syndrome: combined risk of resistance to treatment in patients with schizophrenia from the FACE-SZ cohort.

Journal: Psychiatry research

Published: January 10, 2025

Clinical and inflammatory markers associated with metabolic dysfunction-associated fatty liver disease in a cohort of individuals with chronic schizophrenia (FACE-SZ).

Clinical and inflammatory markers associated with metabolic dysfunction-associated fatty liver disease in a cohort of individuals with chronic schizophrenia (FACE-SZ).

Journal: Journal of psychosomatic research

Published: January 10, 2025

Inflammation, childhood trauma, and symptom dimensions in schizophrenia: a path-analysis study.

Inflammation, childhood trauma, and symptom dimensions in schizophrenia: a path-analysis study.

Journal: Brain, behavior, & immunity - health

Published: January 07, 2025

Prediction of relapse in a French cohort of outpatients with schizophrenia (FACE-SZ): Prediction, not association.

Prediction of relapse in a French cohort of outpatients with schizophrenia (FACE-SZ): Prediction, not association.

Journal: Progress in neuro-psychopharmacology & biological psychiatry

Published: October 29, 2024

Showing 1-12 of 108

Last Updated: 09/26/2026